THE GLOBAL 3D BIOPRINTING MARKET WAS VALUED AT USD 705.17 MILLION IN 2021 AND IS EXPECTED TO REACH USD 2 BILLION BY 2027, GROWING AT A CAGR OF 18.45%.

The 3D Bioprinting Market Size, Share, and Growth Forecast By: 

  • Components: Bioprinters and Bio-Inks
  • Application: Research and Clinical
  • Material: Living Cells, Hydrogels, Extracellular Matrices, and Others
  • End-User: RO & AT, Biopharmaceutical Companies, RM Companies, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2022 – 2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

320 Pages

icon-table

86 Tables

icon-chart

173 Charts

icon-region

5 Regions

icon-country

19 Countries

icon-company

32 Companies

icon-market

5 Market Segment

GLOBAL 3D BIOPRINTING MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 705.17 Billion
Market Size (2021) USD 1.9 Billion
CAGR (2022-2027) 18.45%
Base Year 2021
Forecast Year 2022-2027
Market Segments Component, Application, Material, End-User, Geography
Geographic Analysis North America, Europe, APAC, Latin America, Middle East & Africa

The global 3D Bioprinting market is expected to grow at a CAGR of 18.45% from 2022 to 2027 and is expected to reach USD 1.9 billion by 2027 from USD 705.17 million in 2021. 3D bioprinting is a technique that allows the production of biocompatible materials and complex 3D functional living tissues. It has enabled numerous researchers and manufacturers to mimic the natural tissue microenvironment into an in-house printed 3D tissue model. It has an immense impact on the field of medicine and healthcare. 

The 3D bioprinting market focuses on developing application-specific bio-inks and new biomaterials, which are crucial in advancing Bio-printing tissues and organs for clinical use. Bioprinters and bio-printed tissues have gained significant interest in medicine and pharmaceutics. Besides, bioprinting technology has a broad utility in various application areas such as tissue engineering and regenerative medicine (RM), transplantation, cancer research and drug screening, and high-throughput assays. Bioprinting technology has the most recognized application in tissue engineering. Bioprinters are used to manufacture scaffolds and fabricate anatomically correct patient-specific constructs. In vitro bio-printed tissues such as skin, nerve and bone have been implanted in animals to evaluate their functionality, neovascularization, and engraftment with the host. Bioprinting's future application is expected to be mostly in organ transplantation and drug & toxicity screening.

4D bioprinting can overcome many limitations of 3D printing; hence, it has become a new field in RM and tissue engineering markets. When compared to 3D printing, 4D printing offers various advantages, such as fast growth of smart and multi-materials, more flexible and deformable structures, and can add more potential applications to both 4D and 3D printing. The emergence of 4D bio-printing is gaining momentum in disease management and healthcare innovation. 

Limitations and future challenges of Bioprinting:

  • Bio-inks with lower biocompatibility and mechanical strength
  • Lower resolution and speed of bioprinter
  • Vasculature of tissue structures/constructs is an important challenge in Bio-printing as the tissues need continuous nutrients and oxygen.
  • Ethical and legal issues with 3D Bioprinting
  • The high cost of the method makes it unaffordable to developing countries.
  • Because Bio-printing is a new and novel technology, it should be studied appropriately to ensure it will be safe for humans.

Numerous Bioprinting companies have emerged in the market. Bioprinting can become a new gold standard for the bio-fabrication of tissues in the field of regenerative medicine. 

About 80% of the market comprises established companies, while 20% are start-ups with strong economic growth. Among all types of bioprinters, extrusion-based bioprinters are used most widely because of their lower cost and ease to use. In comparison, the second most common Bio-printing technology is Inkjet-based. Currently, inkjet technology is included in most extrusion-based bioprinters, commercially available as an additional printing head. 

Stereolithography-based bioprinters are a new addition to the bio-printing industry. Laser-assisted bioprinters are one of the most expensive bioprinters. Laser-assisted bioprinters can reach the highest resolutions on the market. The global bioprinting market is growing at a faster rate not only in terms of quantity but also in terms of diversification of the technologies developed and offered. The bioprinting companies are relatively dispersed across all continents. Globally, the US remains the most significant player, exceeding all the other countries. Several Bio-printing companies across the globe currently manufacture commercially available 3D bioprinters, which indicates that the field of Bio-printing is growing rapidly, and many start-ups are entering the market. The technological innovations associated with bioprinters and bio-inks are also increasing rapidly. 

TECHNOLOGICAL ADVANCEMENTS

One of the biggest trends in technological innovations is the development of magnetic bioprinters, Organ. But, a magnetic bioprinter was developed by a Russian company, 3D Bioprinting Solutions. Furthermore, the Japanese company Cyfuse Biomedical developed a platform that allows the creation of scaffold-free tissues using the Kenzan Bio-printing method to manipulate spheroids. Conversely, some companies, such as Germany-based Cellbricks, prefer to produce complex 3D printed cell culture structures with a proprietary non-commercial stereolithography-based Bio-printing platform. 

The enhancement in printing resolution, speed, and cost reduction are common challenges to be faced in the coming future. Germany-based Cellbricks prefer to produce complex 3D-printed cell culture structures with a proprietary non-commercial stereolithography-based Bio-printing platform. Furthermore, some enterprises try to propose bioprinters with more degrees of freedom to increase system flexibility and the range of printable features, like the American company Advanced Solutions, which has patented a six-axis robotic extrusion-based bioprinter arm, BioAssembleBot 400, which can load up to ten independent biomaterials during a single print run. 

Poietis, a France based Bio-printing company, focuses on laser-assisted Bio-printing combined with extrusion-based and inkjet-based technologies supported via a proprietary privacy impact assessment (PIA) software to reconstitute the 3D picture of a complete tissue with all layers. Aspect Biosystems, a Canada-based Bio-printing company, attempts to achieve improved accuracy in developing microfluidic platforms equipped with an on-printhead crosslinking system that can print bioinks with a coaxial shell. 

In 2018, Prellis Biologics, in collaboration with BIOC Group, a leading Bio-printing company, released one of the first systems using two-photons stereolithography to the market, named Holograph X, with a special solution to increase the 3D printing speed by using a parallel set of photons, i.e., a multiphoton technology, to simultaneously cure millions of points in the bioink and turn to achieve Bio-printing speeds of up to 250,000 voxels/second. Some advanced technologies include high resolution, high speed, high accuracy, and 4D bioprinters. Poietis and ROKIT Healthcare are now offering 4D Bio-printing systems. Poietis’s 4D bioprinter, NGB-R, is a laser-assisted Bio-printing system based on four single-cell resolution technologies: computer-assisted design, automated, robotic Bioprinting, in-line monitoring, and tissue formation modeling. It enables true versatility of Bio-printing (from cell to spheroids) and offers the possibility of large biomaterials and hydrogels.

VENDORS' ACTIVITIES IN THE MARKET

The global Bioprinting market is moderately dynamic, with a few key international players and a large pool of start-up vendors that have emerged in recent years offering a comprehensive range of bioprinters. Organovo Holdings, BICO, and Advanced Solutions (ASI) are the key players in the market. Several players focus on developing technologically advanced bioprinters to expand their product portfolio. 

Bioprinting vendors are facing huge competition from many established vendors and emerging companies to become highly competitive. 

Furthermore, the market is experiencing an increase in the product launches from various vendors coupled with R&D activities, thus enabling vendors to expand their presence, enhance market growth, and sustain their market position in the global market. 

Increasing funding and investments by public and private entities, including large companies and governments, are expected to enable emerging international companies and start-ups to develop bioprinters with applications in wide therapeutic areas. Many start-ups are coming up with 3D reconstruction software to be used by researchers for Bio-printing and thus are contributing to the growth of the Bio-printing market. The vendors are still facing regulatory approvals and ethical issues restricting them from growing in the market. Vendor's activities in the Bio-printing market include:

  • Expansion activities are helping the vendors strengthen the global distribution networks and thus allowing the players to explore untapped opportunities.
  • Large-scale investments and funding in the Bio-printing market through varied conglomerates and investments firms
  • Forging partnerships and collaborations with well-established manufacturers cementing the footprints of the players
  • Active Mergers and acquisitions play a crucial role in the smooth functioning of the growth cycle.
  • A diverse range of bioprinters and bio-inks are being offered.
  • The market is witnessing a surge in technological advancements in the field of Bio-printing, and several new product launches can be witnessed.
  • Several vendors are now focusing on developing low-cost, high-resolution, speed, and accuracy bioprinters. BIOC, Advanced Solutions, and ROKIT Healthcare are one of the top companies focused on offering cost-effective 3D bioprinters.
  • Several new start-up companies are entering the market with the increased funding being received by the government and private entities.
  • The market is witnessing a large number of pure players for bioprinters.

Vendors are engaged in developing all sorts of tissues ranging from the 3D bio-printed human testicle cells produced at the University of British Columbia to the bio-printed liver tissues of T&R Biofab. The 3D bioprinting market will have a more significant impact on patient treatment through engineered organ replacements. The notable growth of 3D printing has simplified pharmaceutical applications, enabling the development of customized drug delivery systems and drug screening for individual patients, escalating from conventional approaches that primarily rely on transgenic animal experiments and mass production.

END-USER INSIGHTS

The Research Organizations & Academic Institutes segment has the highest revenue of $276.14 million in 2021 and thus holds the highest market share. North America dominates with an increasing number of research organizations and academic institutes that research Bioprinting and the adoption of bioprinting technologies and thus account for the highest market share. Several US-based research organizations and academic institutes have adopted advanced bioprinting technologies, driven by their increasing collaborations with the leading players to develop 3D functional tissue and organ models. With the growing focus on tissue engineering, and cell and gene therapy, regenerative medicine companies’ segment is expected to witness significant growth during the forecast period with the highest CAGR of 19.47%.

GEOGRAPHY OVERVIEW

The growing rate of medical device manufacturers worldwide has fueled the demand for advanced technologies. Most leading medical device and pharmaceutical companies focus on improving their product portfolio worldwide. The demand in this market is expected to surge in response to the lack of organ donors in adequate numbers. With research and development investment and funding to research organizations and start-up companies is increasing significantly, the market will gain from increasing growth opportunities in the coming years. 

In the past few years, Bio-printing technology has been increasingly preferred by surgeons and patients to precisely perform and plan reconstructive surgery. Therefore, critical developers of Bio-printing are now increasing their product portfolio with the launch of bioprinters and devices as part of their manufacturing strategy, which is expected to provide opportunities for market growth in the forecast period.  

North America and Europe dominate the bio-printing market. Ongoing research on RM and advancements in tissue engineering are being aimed at regenerating damaged tissues and organs with the help of bioprinters. Increasing focus on regenerative and personalized medicine is driving the growth of the Bio-printing market in North America and Europe. Several vendors are coming up with more technological advancements in Bioprinting. The enhancement in printing resolution, speed, and cost reduction are the most common challenges that will continue to be faced in the upcoming years.

Frequently Asked Questions

HOW BIG IS THE GLOBAL BIOPRINTING MARKET?

The global bio-printing market is expected to get nearly double by 2027 crossing USD 705 Billion.

WHAT IS THE GROWTH RATE OF THE BIO-PRINTING MARKET?

The global Bio-printing market will grow at a CAGR of 18.45%.

WHAT ARE THE GROWTH FACTORS IN THE BIO-PRINTING MARKET?

Increasing focus on regenerative medicine, technological advancements in Bioprinting, and investments and fundings for research are the primary growth factor in the market.

WHO ARE THE KEY PLAYERS IN THE BIO-PRINTING MARKET?

Organovo Holdings, BICO, and Advanced Solutions (ASI).

WHAT ARE THE LATEST TRENDS IN THE BIO-PRINTING MARKET?

The latest trends in the market are the emergence of 4D Bioprinting, the growing focus on developing bio-printed organs, and the increasing focus on personalized medicine.

Download Free Sample

The global bio-printing market was valued at USD 705.17 million in 2021 and is expected to reach USD 2 billion by 2027, growing at a CAGR of 18.45%.

The following factors are likely to contribute to the growth of the global bioprinting market during the forecast period:

  • Increasing Focus on Regenerative Medicine
  • Rising Technological Advancements in the field of Bioprinting
  • Growing Focus on Developing Bio-Printed Organs
  • Emergence of 4D Bioprinting

Base Year: 2021

Forecast Year: 2022–2027

The study considers the present scenario of the global bio-printing market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Key Vendors

  • Organovo Holdings
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • BICO
  • Advanced Solutions (ASI)

Other Prominent Vendors

  • Aspect Biosystems
    • Business Overview
    • Product Offerings
  • BIOLIFE4D
  • Brinter
  • Cellbricks
  • CollPlant
  • Cyfuse Biomedical
  • 3D Bio-printing Solutions
  • 3D Systems
  • 3DBio Therapeutics
  • Desktop Metal
  • Foldink
  • Formlabs
  • FELIXprinters
  • Fluicell
  • GeSiM
  • Hangzhou Jienuofei Biotechnology
  • Inventia Life Science
  • LIfe SI
  • Medprin
  • Next Big Innovation Labs
  • Ourobionics
  • Poietis
  • Precise Bio
  • Prellis Biologics
  • ROKIT Healthcare
  • REGENHU
  • Stratasys
  • TissueLabs

Market Segmentation by Components

  • 3d Bioprinters
  • Bio-Inks

Market Segmentation by Application

  • Research
  • Clinical

Market Segmentation by Material

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Others

Market Segmentation by End-User

  • RO & AT
  • Biopharmaceutical Companies
  • RM Companies
  • Others

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • APAC
    • Japan
    • China
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • South Africa

1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS

4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY MATERIAL
4.3.4 MARKET SEGMENTATION BY END USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW

8 PREMIUM INSIGHTS
8.1 MARKET OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS
9.1 EMERGENCE OF 4D BIOPRINTING
9.2 RISE IN FOCUS ON 3D ORGAN BIOPRINTING
9.3 HIGH FOCUS ON PERSONALIZED MEDICINE

10 MARKET GROWTH ENABLERS
10.1 SURGE IN FOCUS ON REGENERATIVE MEDICINE
10.2 ADVANCES IN BIOPRINTING TECHNOLOGIES
10.3 RISE IN FUNDING FOR R&D INITIATIVES

11 MARKET RESTRAINTS
11.1 HIGH COST OF BIOPRINTING TECHNOLOGIES
11.2 BIOETHICAL AND LEGAL ISSUES
11.3 REGULATORY BARRIERS FOR BIOPRINTING MARKET

12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY COMPONENTS
12.2.2 INSIGHTS BY APPLICATION
12.2.3 INSIGHTS BY MATERIAL
12.2.4 INSIGHTS BY END USER
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY

13 COMPONENT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 3D BIOPRINTERS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 BIOINKS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY

14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 RESEARCH
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 CLINICAL
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY

15 MATERIAL
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 LIVING CELLS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 HYDROGELS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 EXTRACELLULAR MATRICES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
15.6 OTHERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 MARKET BY GEOGRAPHY

16 END USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 RESEARCH ORGANIZATION & ACADEMIC INSTITUTES
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 BIOPHARMACEUTICAL COMPANIES
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 RM COMPANIES
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NORTH AMERICA: COMPONENT
18.4 NORTH AMERICA: APPLICATION
18.5 NORTH AMERICA: MATERIAL
18.6 NORTH AMERICA: END USER
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 EUROPE: COMPONENT
19.4 EUROPE: APPLICATION
19.5 EUROPE: MATERIAL
19.6 EUROPE: END USER
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 FRANCE: MARKET SIZE & FORECAST
19.7.3 UK: MARKET SIZE & FORECAST
19.7.4 SPAIN: MARKET SIZE & FORECAST
19.7.5 ITALY: MARKET SIZE & FORECAST

20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 APAC: COMPONENT
20.4 APAC: APPLICATION
20.5 APAC: MATERIAL
20.6 APAC: END USER
20.7 KEY COUNTRIES
20.7.1 JAPAN: MARKET SIZE & FORECAST
20.7.2 CHINA: MARKET SIZE & FORECAST
20.7.3 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.4 INDIA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 LATIN AMERICA: COMPONENT
21.4 LATIN AMERICA: APPLICATION
21.5 LATIN AMERICA: MATERIAL
21.6 LATIN AMERICA: END USER
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 MIDDLE EAST & AFRICA: COMPONENT
22.4 MIDDLE EAST & AFRICA: APPLICATION
22.5 MIDDLE EAST & AFRICA: MATERIAL
22.6 MIDDLE EAST & AFRICA: END USER
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 UAE: MARKET SIZE & FORECAST
22.7.4 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 ORGANOVO HOLDINGS
23.2.2 BICO
23.2.3 ADVANCED SOLUTIONS LIFE SCIENCES (ASLS)

24 KEY COMPANY PROFILES
24.1 ORGANOVO HOLDINGS
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 BICO
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 ADVANCED SOLUTIONS
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS
25.1 ASPECT BIOSYSTEMS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 BIOLIFE4D
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 BRINTER
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 CELLBRICKS
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 COLLPLANT
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 CYFUSE BIOMEDICAL
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 3D BIOPRINTING SOLUTIONS
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 3D SYSTEMS
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 3DBIO THERAPEUTICS
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 DESKTOP METAL
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 FOLDINK
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 FORMLABS
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 FELIXPRINTERS
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 FLUICELL
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 GESIM
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 HANGZHOU JIENUOFEI BIOTECHNOLOGY
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 INVENTIA LIFE SCIENCE
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 LIFE SI
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 MEDPRIN
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 NEXT BIG INNOVATION LABS
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 NSCRYPT
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 OUROBIONICS
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 POIETIS
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 PRECISE BIO
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 PRELLIS BIOLOGICS
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 ROKIT HEALTHCARE
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS
25.27 REGENHU
25.27.1 BUSINESS OVERVIEW
25.27.2 PRODUCT OFFERINGS
25.28 STRATASYS
25.28.1 BUSINESS OVERVIEW
25.28.2 PRODUCT OFFERINGS
25.29 TISSUELABS
25.29.1 BUSINESS OVERVIEW
25.29.2 PRODUCT OFFERINGS

26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY COMPONENT
27.3 MARKET BY APPLICATION
27.4 MARKET BY MATERIAL
27.5 MARKET BY END USER
27.6 NORTH AMERICA BY COMPONENT
27.7 NORTH AMERICA BY APPLICATION
27.8 NORTH AMERICA BY MATERIAL
27.9 NORTH AMERICA BY END USER
27.10 EUROPE BY COMPONENT
27.11 EUROPE BY APPLICATION
27.12 EUROPE BY MATERIAL
27.13 EUROPE BY END USER
27.14 APAC BY COMPONENT
27.15 APAC BY APPLICATION
27.16 APAC BY MATERIAL
27.17 APAC BY END USER
27.18 LATIN AMERICA BY COMPONENT
27.19 LATIN AMERICA BY APPLICATION
27.20 LATIN AMERICA BY MATERIAL
27.21 LATIN AMERICA BY END USER
27.22 MIDDLE EAST & AFRICA BY COMPONENT
27.23 MIDDLE EAST & AFRICA BY APPLICATION
27.24 MIDDLE EAST & AFRICA BY MATERIAL
27.25 MIDDLE EAST & AFRICA BY END USER

28 APPENDIX
28.1 ABBREVIATIONS

EXHIBIT 1 SEGMENTATION OF GLOBAL BIOPRINTING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 BIOTECHNOLOGY COMPANIES SPECIALIZING IN BIOENGINEERED IN VITRO TISSUE MODELS TO STUDY SARS-COV-2 INFECTION
EXHIBIT 4 GROWTH DRIVERS FOR GLOBAL BIOPRINTING MARKET
EXHIBIT 5 OVERVIEW OF END-USER SEGMENTS
EXHIBIT 6 GLOBAL BIOPRINTING MARKET: GEOGRAPHICAL OVERVIEW
EXHIBIT 7 IMPACT OF EMERGENCE OF 4D BIOPRINTING
EXHIBIT 8 PROCESSES AND APPLICATIONS OF 4D BIOPRINTING
EXHIBIT 9 IMPACT OF RISE IN FOCUS ON 3D ORGAN BIOPRINTING
EXHIBIT 10 PATIENTS ON WAITING LIST VS. TRANSPLANTS PERFORMED (BY ORGAN) 2021
EXHIBIT 11 ESTIMATED DURATION FOR BIOPRINTING TO REPLACE DONOR ORGANS (BASED ON PERCENTAGE OF RESPONDENTS)
EXHIBIT 12 IMPACT OF HIGH FOCUS ON PERSONALIZED MEDICINE
EXHIBIT 13 REPRESENTATION OF VARIOUS 3D PRINTING TECHNIQUES USED IN DESIGNING DOSAGE FORMS FOR PERSONALIZED DRUG DELIVERY
EXHIBIT 14 IMPACT OF SURGE IN FOCUS ON REGENERATIVE MEDICINE
EXHIBIT 15 TOTAL GLOBAL REGENERATIVE MEDICINE FINANCING ($ BILLION)
EXHIBIT 16 IMPACT OF ADVANCES IN BIOPRINTING TECHNOLOGIES
EXHIBIT 17 IMPACT OF RISE IN FUNDING FOR R&D INITIATIVES
EXHIBIT 18 IMPACT OF HIGH COST OF BIOPRINTING TECHNOLOGIES
EXHIBIT 19 COSTS OF VARIOUS BIOPRINTERS FROM DIFFERENT COMPANIES 2020 ($)
EXHIBIT 20 COSTS OF VARIOUS BIOINKS
EXHIBIT 21 IMPACT OF BIOETHICAL AND LEGAL ISSUES
EXHIBIT 22 IMPACT OF REGULATORY BARRIERS FOR BIOPRINTING MARKET
EXHIBIT 23 MAJOR GROWTH DETERRENTS FOR BIOPRINTING SECTOR
EXHIBIT 24 BUSINESS MODELS OF COMPANIES OFFERING COMMERCIALIZED PRODUCTS
EXHIBIT 25 GLOBAL BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 26 GLOBAL BIOPRINTING MARKET BY COMPONENTS 2021 & 2027 (%)
EXHIBIT 27 GLOBAL BIOPRINTING MARKET BY APPLICATION 2021 & 2027 (%)
EXHIBIT 28 GLOBAL BIOPRINTING MARKET BY MATERIAL 2021 & 2027 (%)
EXHIBIT 29 GLOBAL BIOPRINTING MARKET BY END USER 2021 & 2027 (%)
EXHIBIT 30 GLOBAL BIOPRINTING MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 31 FIVE FORCES ANALYSIS 2021
EXHIBIT 32 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 33 GLOBAL BIOPRINTING MARKET BY COMPONENT
EXHIBIT 34 GLOBAL BIOPRINTING MARKET BY COMPONENT: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 35 GLOBAL BIOPRINTING MARKET BY COMPONENT: ABSOLUTE GROWTH (%)
EXHIBIT 36 GLOBAL BIOPRINTING MARKET BY COMPONENT
EXHIBIT 37 GROWTH ANALYSIS: GLOBAL BIOPRINTING MARKET BY COMPONENTS
EXHIBIT 38 COMMERCIALLY AVAILABLE 3D BIOPRINTERS
EXHIBIT 39 GLOBAL BIOPRINTING MARKET BY 3D BIOPRINTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL BIOPRINTING MARKET BY 3D BIOPRINTERS 2021–2027 ($ MILLION)
EXHIBIT 41 3D BIOPRINTERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 42 KEY REQUIREMENTS FOR SELECTING BIOINKS FOR 3D PRINTING IN TERMS OF BIOMATERIALS
EXHIBIT 43 OVERVIEW OF COMMERCIALLY AVAILABLE BIO-INKS
EXHIBIT 44 GLOBAL BIOPRINTING MARKET BY BIOINKS 2021–2027 ($ MILLION)
EXHIBIT 45 GLOBAL BIOPRINTING MARKET BY 3D BIOPRINTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 BIOINKS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 48 GLOBAL BIOPRINTING MARKET BY APPLICATION
EXHIBIT 49 GLOBAL BIOPRINTING MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 50 GLOBAL BIOPRINTING MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 51 GLOBAL BIOPRINTING MARKET BY APPLICATION
EXHIBIT 52 GROWTH ANALYSIS: GLOBAL BIOPRINTING MARKET BY APPLICATION
EXHIBIT 53 GLOBAL BIOPRINTING MARKET BY RESEARCH APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL BIOPRINTING MARKET BY RESEARCH APPLICATIONS 2021–2027 ($ MILLION)
EXHIBIT 55 RESEARCH APPLICATIONS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 56 GLOBAL BIOPRINTING MARKET BY CLINICAL APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL BIOPRINTING MARKET BY CLINICAL APPLICATIONS 2021–2027 ($ MILLION)
EXHIBIT 58 CLINICAL APPLICATIONS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 59 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 60 GLOBAL BIOPRINTING MARKET BY MATERIAL
EXHIBIT 61 GLOBAL BIOPRINTING MARKET BY MATERIAL: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 62 GLOBAL BIOPRINTING MARKET BY MATERIAL: ABSOLUTE GROWTH (%)
EXHIBIT 63 GLOBAL BIOPRINTING MARKET BY MATERIAL
EXHIBIT 64 GROWTH ANALYSIS: GLOBAL BIOPRINTING MARKET BY MATERIAL
EXHIBIT 65 GLOBAL BIOPRINTING MARKET BY LIVING CELLS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL BIOPRINTING MARKET BY LIVING CELLS 2021–2027 ($ MILLION)
EXHIBIT 67 LIVING CELLS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 68 ADVANTAGES AND DISADVANTAGES OF HYDROGELS IN TISSUE ENGINEERING
EXHIBIT 69 GLOBAL BIOPRINTING MARKET BY HYDROGELS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 70 GLOBAL BIOPRINTING MARKET BY HYDROGELS 2021–2027 ($ MILLION)
EXHIBIT 71 HYDROGELS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 72 GLOBAL BIOPRINTING MARKET BY EXTRACELLULAR MATRICES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL BIOPRINTING MARKET BY EXTRACELLULAR MATRICES,2021–2027 ($ MILLION)
EXHIBIT 74 EXTRACELLULAR MATRICES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 75 GLOBAL BIOPRINTING MARKET BY OTHER MATERIALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 OVERVIEW OF POPULAR ADDITIVES AS BIOMATERIALS USED IN BIOPRINTING
EXHIBIT 77 GLOBAL BIOPRINTING MARKET BY OTHER MATERIALS 2021–2027 ($ MILLION)
EXHIBIT 78 OTHER MATERIALS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 80 GLOBAL BIOPRINTING MARKET BY END USER
EXHIBIT 81 GLOBAL BIOPRINTING MARKET BY END USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 82 GLOBAL BIOPRINTING MARKET BY END USER: ABSOLUTE GROWTH (%)
EXHIBIT 83 GLOBAL BIOPRINTING MARKET BY END USER
EXHIBIT 84 GROWTH ANALYSIS: GLOBAL BIOPRINTING END-USER MARKET BY REGION
EXHIBIT 85 GLOBAL BIOPRINTING MARKET BY RESEARCH ORGANIZATION & ACADEMIC INSTITUTES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 86 GLOBAL BIOPRINTING MARKET BY RESEARCH ORGANIZATION & ACADEMIC INSTITUTES 2021–2027 ($ MILLION)
EXHIBIT 87 RESEARCH ORGANIZATION & ACADEMIC INSTITUTES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 88 GLOBAL BIOPRINTING MARKET BY BIOPHARMACEUTICAL COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 89 APPLICATIONS OF BIOPRINTING IN PHARMACEUTICAL INDUSTRY
EXHIBIT 90 GLOBAL BIOPRINTING MARKET BY BIOPHARMACEUTICAL COMPANIES 2021–2027 ($ MILLION)
EXHIBIT 91 BIOPHARMACEUTICAL COMPANIES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 92 GLOBAL BIOPRINTING MARKET BY RM COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 93 GLOBAL BIOPRINTING MARKET BY RM COMPANIES 2021–2027 ($ MILLION)
EXHIBIT 94 RM COMPANIES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 95 ADVANTAGES AND DRAWBACKS OF SKIN BIOPRINTING
EXHIBIT 96 COMPARISON OF METHODS APPLIED IN SKIN BIOPRINTING
EXHIBIT 97 GLOBAL BIOPRINTING MARKET BY OTHER END USERS 2021–2027 ($ MILLION)
EXHIBIT 98 GLOBAL BIOPRINTING MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 OTHER END USERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 100 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 101 GLOBAL BIOPRINTING MARKET BY GEOGRAPHY
EXHIBIT 102 GLOBAL BIOPRINTING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 103 GLOBAL BIOPRINTING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 104 NORTH AMERICA BIOPRINTING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 105 NORTH AMERICA BIOPRINTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 106 NORTH AMERICA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 107 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 108 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 109 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 110 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 111 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 112 NUMBER OF HOSPITALS WITH CENTRALIZED 3D BIOPRINTING FACILITY IN US 2010–2016
EXHIBIT 113 US BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 114 CANADA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 EUROPE BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 116 EUROPE BIOPRINTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 117 EUROPE BIOPRINTING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 118 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 123 NUMBER OF TRANSPLANTS AND ORGAN DONORS IN GERMANY 2013–2021
EXHIBIT 124 ORGAN TRANSPLANTATIONS IN GERMANY 2021 (%)
EXHIBIT 125 GERMANY BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 126 FRANCE BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 127 UK BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 128 SPAIN BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 129 ITALY BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 130 APAC BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 131 APAC BIOPRINTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 132 APAC BIOPRINTING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 133 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 134 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 135 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 136 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 137 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 138 JAPAN BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 139 CHINA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 140 SOUTH KOREA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 141 INDIA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 142 AUSTRALIA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 143 LATIN AMERICA BIOPRINTING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 144 LATIN AMERICA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 145 LATIN AMERICA BIOPRINTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 146 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 147 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 148 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 149 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 150 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 151 BRAZIL BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 152 MEXICO BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 153 ARGENTINA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 154 MIDDLE EAST & AFRICA BIOPRINTING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 155 MIDDLE EAST & AFRICA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 156 MIDDLE EAST & AFRICA BIOPRINTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 157 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 158 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 159 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 160 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 161 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 162 TURKEY BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 163 SAUDI ARABIA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 164 UAE BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 165 SOUTH AFRICA BIOPRINTING MARKET 2021–2027 ($ MILLION)
EXHIBIT 166 PURE & DIVERSIFIED COMPANIES IN GLOBAL BIOPRINTING MARKET
EXHIBIT 167 GLOBAL BIOPRINTING MARKET: MARKET DOMINANCE ANALYSIS
EXHIBIT 168 VENDORS IN GLOBAL BIOPRINTING MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 169 ORGANOVO HOLDINGS: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 170 ORGANOVO HOLDINGS: TOTAL R& D EXPENDITURES 2019–2021 ($ MILLION)
EXHIBIT 171 BICO: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 172 BICO GROUP: TOTAL REVENUE BY LABORATORY SOLUTIONS SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 173 BICO GROUP: GLOBAL MARKET SHARE OF LABORATORY SOLUTIONS SEGMENT 2021 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 FUNDING FOR 3D BIOPRINTING INITIATIVES BY START-UPS ($ MILLION)
TABLE 4 ADVANTAGES AND DISADVANTAGES OF 3D BIOPRINTING
TABLE 5 ORGANOVO HOLDINGS: MAJOR PRODUCT OFFERINGS
TABLE 6 BICO: MAJOR PRODUCT OFFERINGS
TABLE 7 ADVANCED SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 8 ASPECT BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 9 BIOLIFE4D: MAJOR PRODUCT OFFERINGS
TABLE 10 BRINTER: MAJOR PRODUCT OFFERINGS
TABLE 11 CELLBRICKS: MAJOR PRODUCT OFFERINGS
TABLE 12 COLLPLANT: MAJOR PRODUCT OFFERINGS
TABLE 13 CYFUSE BIOMEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 14 3D BIOPRINTING SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 15 3D SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 16 3DBIO THERAPEUTICS: MAJOR PRODUCT OFFERINGS
TABLE 17 DESKTOP METAL: MAJOR PRODUCT OFFERINGS
TABLE 18 FOLDINK: MAJOR PRODUCT OFFERINGS
TABLE 19 FORMLABS: MAJOR PRODUCT OFFERINGS
TABLE 20 FELIXPRINTERS: MAJOR PRODUCT OFFERINGS
TABLE 21 FLUICELL: MAJOR PRODUCT OFFERINGS
TABLE 22 GESIM: MAJOR PRODUCT OFFERINGS
TABLE 23 HANGZHOU JIENUOFEI BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 24 INVENTIA LIFE SCIENCE: MAJOR PRODUCT OFFERINGS
TABLE 25 LIFE SI: MAJOR PRODUCT OFFERINGS
TABLE 26 MEDPRIN: MAJOR PRODUCT OFFERINGS
TABLE 27 NEXT BIG INNOVATION LABS: MAJOR PRODUCT OFFERINGS
TABLE 28 NSCRYPT: MAJOR PRODUCT OFFERINGS
TABLE 29 OUROBIONICS: MAJOR PRODUCT OFFERINGS
TABLE 30 POIETIS: MAJOR PRODUCT OFFERINGS
TABLE 31 PRECISEBIO: MAJOR PRODUCT OFFERINGS
TABLE 32 PRELLIS BIOLOGICS: MAJOR PRODUCT OFFERINGS
TABLE 33 ROKIT HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 34 REGENHU: MAJOR PRODUCT OFFERINGS
TABLE 35 STRATASYS: MAJOR PRODUCT OFFERINGS
TABLE 36 TISSUELABS: MAJOR PRODUCT OFFERINGS
TABLE 37 GLOBAL BIOPRINTING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 38 GLOBAL BIOPRINTING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 39 GLOBAL BIOPRINTING MARKET BY COMPONENT 2021–2027 ($ MILLION)
TABLE 40 GLOBAL BIOPRINTING MARKET BY COMPONENT 2021–2027 (%)
TABLE 41 GLOBAL BIOPRINTING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 42 GLOBAL BIOPRINTING MARKET BY APPLICATION 2021–2027 (%)
TABLE 43 GLOBAL BIOPRINTING MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 44 GLOBAL BIOPRINTING MARKET BY MATERIAL 2021–2027 (%)
TABLE 45 GLOBAL BIOPRINTING MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 46 GLOBAL BIOPRINTING MARKET BY END USER 2021–2027 (%)
TABLE 47 NORTH AMERICA BIOPRINTING MARKET BY COMPONENT 2021–2027 ($ MILLION)
TABLE 48 NORTH AMERICA BIOPRINTING MARKET BY COMPONENT 2021–2027 (%)
TABLE 49 NORTH AMERICA BIOPRINTING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 50 NORTH AMERICA BIOPRINTING MARKET BY APPLICATION 2021–2027 (%)
TABLE 51 NORTH AMERICA BIOPRINTING MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 52 NORTH AMERICA BIOPRINTING MARKET BY MATERIAL 2021–2027 (%)
TABLE 53 NORTH AMERICA BIOPRINTING MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 54 NORTH AMERICA BIOPRINTING MARKET BY END USER 2021–2027 (%)
TABLE 55 EUROPE BIOPRINTING MARKET BY COMPONENT 2021–2027 ($ MILLION)
TABLE 56 EUROPE BIOPRINTING MARKET BY COMPONENT 2021–2027 (%)
TABLE 57 EUROPE BIOPRINTING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 58 EUROPE BIOPRINTING MARKET BY APPLICATION 2021–2027 (%)
TABLE 59 EUROPE BIOPRINTING MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 60 EUROPE BIOPRINTING MARKET BY MATERIAL 2021–2027 (%)
TABLE 61 EUROPE BIOPRINTING MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 62 EUROPE BIOPRINTING MARKET BY END USER 2021–2027 (%)
TABLE 63 APAC BIOPRINTING MARKET BY COMPONENT 2021–2027 ($ MILLION)
TABLE 64 APAC BIOPRINTING MARKET BY COMPONENT 2021–2027 (%)
TABLE 65 APAC BIOPRINTING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 66 APAC BIOPRINTING MARKET BY APPLICATION 2021–2027 (%)
TABLE 67 APAC BIOPRINTING MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 68 APAC BIOPRINTING MARKET BY MATERIAL 2021–2027 (%)
TABLE 69 APAC BIOPRINTING MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 70 APAC BIOPRINTING MARKET BY END USER 2021–2027 (%)
TABLE 71 LATIN AMERICA BIOPRINTING MARKET BY COMPONENT 2021–2027 ($ MILLION)
TABLE 72 LATIN AMERICA BIOPRINTING MARKET BY COMPONENT 2021–2027 (%)
TABLE 73 LATIN AMERICA BIOPRINTING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 74 LATIN AMERICA BIOPRINTING MARKET BY APPLICATION 2021–2027 (%)
TABLE 75 LATIN AMERICA BIOPRINTING MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 76 LATIN AMERICA BIOPRINTING MARKET BY MATERIAL 2021–2027 (%)
TABLE 77 LATIN AMERICA BIOPRINTING MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 78 LATIN AMERICA BIOPRINTING MARKET BY END USER 2021–2027 (%)
TABLE 79 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY COMPONENT 2021–2027 ($ MILLION)
TABLE 80 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY COMPONENT 2021–2027 (%)
TABLE 81 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 82 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY APPLICATION 2021–2027 (%)
TABLE 83 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY MATERIAL 2021–2027 ($ MILLION)
TABLE 84 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY MATERIAL 2021–2027 (%)
TABLE 85 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY END USER 2021–2027 ($ MILLION)
TABLE 86 MIDDLE EAST & AFRICA BIOPRINTING MARKET BY END USER 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date